Stryker reports second quarter 2023 operating results

Pharmaceutical giant Stryker has reported its second quarter net sales growth of $5.2bn (£4.5bн) in the first three months of the year, according to a report from the US financial regulator. Reports have revealed further data.

Source: orthospinenews.com
Published on 2023-08-03